Knight Therapeutics Inc. (TSX: GUD)
Canada
· Delayed Price · Currency is CAD
6.00
+0.21 (3.63%)
May 31, 2024, 4:00 PM EDT
Knight Therapeutics Market Cap
Knight Therapeutics has a market cap or net worth of 608.26 million as of May 31, 2024.
Market Cap
608.26M
Enterprise Value
504.08M
Revenue
332.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.00
Market Cap Chart
Since December 31, 2014, Knight Therapeutics's market cap has increased from 396.16M to 608.26M, an increase of 53.54%. That is a compound annual growth rate of 4.66%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 608.26M | 9.06% |
Dec 31, 2023 | 557.75M | -6.28% |
Dec 31, 2022 | 595.13M | -9.79% |
Dec 31, 2021 | 659.75M | -6.42% |
Dec 31, 2020 | 705.04M | -33.45% |
Dec 31, 2019 | 1.06B | -3.55% |
Dec 31, 2018 | 1.10B | -5.72% |
Dec 31, 2017 | 1.16B | -10.15% |
Dec 31, 2016 | 1.30B | 74.60% |
Dec 31, 2015 | 742.60M | 87.45% |
Dec 31, 2014 | 396.16M | 80.68% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Bausch + Lomb Corporation | 7.39B |
Bausch Health Companies Inc. | 3.08B |
Tilray Brands, Inc. | 2.03B |
Sienna Senior Living Inc. | 1.05B |
WELL Health Technologies Corp. | 903.91M |
Canopy Growth Corporation | 883.13M |
Extendicare Inc. | 613.70M |
Medical Facilities Corporation | 288.75M |